TRAF2 is a well-known regulator protein of TNFα-NFκB signaling, shown to be enriched in the GSEA analysis of lung cancer patients with KEAP1 mutation in sites R320 and R470 (Fig. 1D and E). This evidence concerns the gene TRAF2 and lung cancer.